Arne Gessner

16PUBLICATIONS
43CO-AUTHORS
Pharmaceutical delivery technologiesMolecular targetsBiomolecular modelling and designToxicology (incl. clinical toxicology)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 01, 2026
Effects of SGLT-2 Inhibitors on Plasma Concentrations and Renal Clearance of the Risk Marker Trimethylamine-N-Oxide in Patients With Type-2 Diabetes.

|Jul 24, 2026
Treatment with dapagliflozin and empagliflozin reduces concentrations of N4-acetylcytidine in plasma, a biomarker associated with vascular damage.

|Jul 04, 2026
Effects of Trimethoprim on Three Previously Proposed Putative Biomarkers for OCT2/MATE-Mediated Renal Drug-Drug Interactions in Healthy Volunteers.

|Jun 03, 2026
Deorphanisation and functional characterisation of OATP5A1 as transport protein for amino acids and vitamins.

|Apr 01, 2026
TNF alpha unmasks enteric malate aspartate shuttle dysfunction bridging Parkinson disease and intestinal inflammation.

Bruno Ghirotto, Luís Eduardo Gonçalves, Vivien Ruder

|Apr 08, 2025
TNF-α disrupts the malate-aspartate shuttle, driving metabolic rewiring in iPSC-derived enteric neural lineages from Parkinson's Disease patients.

Bruno Ghirotto, Luís Eduardo Gonçalves, Vivien Ruder

Pageof 3

Frequent Collaborators

11 joint publications

Martin F Fromm

6 joint publications

Jörg König

4 joint publications

Renke Maas

4 joint publications

Fabian Müller